Abstract:Ubiquitin-like proteins (UBLs) constitute a family of evolutionarily conserved proteins that share similarities with ubiquitin in 3D structures and modification mechanisms. For most UBLs including Small-Ubiquitin-like Modifiers (SUMO), their modification sites on substrate proteins cannot be identified using the mass spectrometry-based method that has been successful for identifying ubiquitination sites, unless a UBL protein is mutated accordingly. To identify UBL modification sites without having to mutate UBL, we have developed a dedicated search engine pLink-UBL on the basis of pLink, a software tool for identification of cross-linked peptide pairs. pLink-UBL exhibited superior precision, sensitivity, and speed than make-do search engines such as MaxQuant, pFind, and pLink. For example, compared to MaxQuant, pLink-UBL increased the number of identified SUMOylation sites by 50 ~ 300% from the same datasets. Additionally, we present a method for identifying small-molecule modifications of UBLs. This method involves antibody enrichment of a UBL C-terminal peptide following enrichment of a UBL protein, followed by LC-MS/MS analysis and a pFind 3 blind search to identify unexpected modifications. Using this method, we have discovered non-protein substrates of SUMO, of which spermidine is the major one for fission yeast SUMO Pmt3. Spermidine can be conjugated to the C-terminal carboxylate group of Pmt3 through its N1 or also likely, N8 amino group in the presence of SUMO E1, E2, and ATP. Pmt3-spermidine conjugation does not require E3 and can be reversed by SUMO isopeptidase Ulp1. SUMO-spermidine conjugation is present in mice and humans. Also, spermidine can be conjugated to ubiquitin in vitro by E1 and E2 in the presence of ATP. The above observations suggest that spermidine may be a common small molecule substrate of SUMO and possibly ubiquitin across eukaryotic species.

Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation

Biochemical and Mass Spectrometry-Based Approaches to Profile SUMOylation in Human Cells.

Antibody-free enrichment method for proteome-wide analysis of endogenous SUMOylation sites

The Strategies for Identification and Quantification of SUMOylation

Proteome-wide Mapping of Endogenous SUMOylation Sites in Mouse Testis.

UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites

Signalling mechanisms and cellular functions of SUMO

SUMO conjugation – a mechanistic view

SUMO is a pervasive regulator of meiosis

Global analysis of protein and small-molecule substrates of ubiquitin-like proteins (UBLs)

Highly sensitive site-specific SUMOylation proteomics in Arabidopsis

Monoclonal antibody-based systematic identification of SUMO1-modification sites reveals TFII-I SUMOylation is involved in tumor growth

Site-specific identification and quantitation of endogenous SUMOylation based on SUMO-specific protease and strong anion exchange chromatography

SUMO paralogue–specific functions revealed through systematic analysis of human knockout cell lines and gene expression data

Mapping Cryptic Phosphorylation Sites in the Human Proteome

Proteome-wide Analysis of SUMO2 Targets in Response to Pathological DNA Replication Stress in Human Cells.

Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation

SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic Studies

SUMO proteases: from cellular functions to disease

Global Screening of Sentrin-Specific Protease Family Substrates in SUMOylation

Multifaceted roles of SUMO in DNA metabolism